# OnCo record gadoxetate-disodium (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gadoxetate-disodium/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gadoxetate-disodium" ;
  schema:name "Gadoxetate disodium (liver-specific MRI contrast)"@en ;
  schema:alternateName "gadoxetate"@en, "gadoxetic acid"@en, "Eovist"@en, "Eovist" ;
  schema:description "An MRI dye injected into a vein that is absorbed by healthy liver cells, so spots in the liver that are not normal liver tissue show up clearly. It is used to find and characterise liver tumours."@en ;
  schema:url <https://onco.cc/drugs/gadoxetate-disodium/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022090>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6218b1e1-cbc3-4c14-bec7-528ac163a561>, <https://atcddd.fhi.no/atc_ddd_index/?code=V08CA&showdescription=no> ;
  onco:status "approved" ;
  onco:tag "contrast-agents-gaps-2026-11", "diagnostic" ;
  onco:modality "Gadolinium-based contrast agent for MRI of the liver (intravenous)" ;
  onco:approval "US 2008: MRI of the liver to detect and characterise lesions in known or suspected focal liver disease" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:technologies <https://onco.cc/technologies/gadolinium-based-contrast-agents/>, <https://onco.cc/technologies/mri/> ;
  onco:companies <https://onco.cc/companies/bayer/> .